Organogenesis Holdings Statistics
Total Valuation
ORGO has a market cap or net worth of $301.10 million. The enterprise value is $280.58 million.
| Market Cap | 301.10M |
| Enterprise Value | 280.58M |
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ORGO has 128.67 million shares outstanding. The number of shares has decreased by -2.43% in one year.
| Current Share Class | 128.67M |
| Shares Outstanding | 128.67M |
| Shares Change (YoY) | -2.43% |
| Shares Change (QoQ) | -3.34% |
| Owned by Insiders (%) | 38.92% |
| Owned by Institutions (%) | 41.44% |
| Float | 57.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| Forward PS | 0.98 |
| PB Ratio | 1.23 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | 17.63 |
| P/OCF Ratio | 9.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.79, with an EV/FCF ratio of 16.43.
| EV / Earnings | n/a |
| EV / Sales | 0.55 |
| EV / EBITDA | 7.79 |
| EV / EBIT | 16.79 |
| EV / FCF | 16.43 |
Financial Position
The company has a current ratio of 3.53, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.53 |
| Quick Ratio | 2.74 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 1.21 |
| Debt / FCF | 4.15 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.73% and return on invested capital (ROIC) is 2.72%.
| Return on Equity (ROE) | 0.73% |
| Return on Assets (ROA) | 2.12% |
| Return on Invested Capital (ROIC) | 2.72% |
| Return on Capital Employed (ROCE) | 3.76% |
| Weighted Average Cost of Capital (WACC) | 9.34% |
| Revenue Per Employee | $602,698 |
| Profits Per Employee | -$17,033 |
| Employee Count | 854 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 4.65 |
Taxes
In the past 12 months, ORGO has paid $1.56 million in taxes.
| Income Tax | 1.56M |
| Effective Tax Rate | 36.47% |
Stock Price Statistics
The stock price has decreased by -28.00% in the last 52 weeks. The beta is 1.33, so ORGO's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | -28.00% |
| 50-Day Moving Average | 2.45 |
| 200-Day Moving Average | 3.81 |
| Relative Strength Index (RSI) | 43.72 |
| Average Volume (20 Days) | 854,212 |
Short Selling Information
The latest short interest is 13.30 million, so 10.33% of the outstanding shares have been sold short.
| Short Interest | 13.30M |
| Short Previous Month | 16.23M |
| Short % of Shares Out | 10.33% |
| Short % of Float | 23.17% |
| Short Ratio (days to cover) | 8.66 |
Income Statement
In the last 12 months, ORGO had revenue of $514.70 million and -$14.55 million in losses. Loss per share was -$0.12.
| Revenue | 514.70M |
| Gross Profit | 380.31M |
| Operating Income | 16.71M |
| Pretax Income | 4.28M |
| Net Income | -14.55M |
| EBITDA | 36.00M |
| EBIT | 16.71M |
| Loss Per Share | -$0.12 |
Balance Sheet
The company has $91.38 million in cash and $70.86 million in debt, with a net cash position of $20.52 million or $0.16 per share.
| Cash & Cash Equivalents | 91.38M |
| Total Debt | 70.86M |
| Net Cash | 20.52M |
| Net Cash Per Share | $0.16 |
| Equity (Book Value) | 381.35M |
| Book Value Per Share | 1.90 |
| Working Capital | 192.48M |
Cash Flow
In the last 12 months, operating cash flow was $30.75 million and capital expenditures -$13.67 million, giving a free cash flow of $17.08 million.
| Operating Cash Flow | 30.75M |
| Capital Expenditures | -13.67M |
| Depreciation & Amortization | 19.29M |
| Net Borrowing | -10.73M |
| Free Cash Flow | 17.08M |
| FCF Per Share | $0.13 |
Margins
Gross margin is 73.89%, with operating and profit margins of 3.25% and 0.53%.
| Gross Margin | 73.89% |
| Operating Margin | 3.25% |
| Pretax Margin | 0.83% |
| Profit Margin | 0.53% |
| EBITDA Margin | 7.00% |
| EBIT Margin | 3.25% |
| FCF Margin | 3.32% |
Dividends & Yields
ORGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.43% |
| Shareholder Yield | n/a |
| Earnings Yield | -4.83% |
| FCF Yield | 5.67% |
Analyst Forecast
The average price target for ORGO is $3.00, which is 28.21% higher than the current price. The consensus rating is "Hold".
| Price Target | $3.00 |
| Price Target Difference | 28.21% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -12.98% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ORGO has an Altman Z-Score of 3.69 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.69 |
| Piotroski F-Score | 4 |